Skip to main content
TipRanks
Go Ultimate75% OFF

Immunome (IMNM) Q2 2023 Earnings Report

468 Followers

IMNM Q2 2023 EPS Results

Actual EPS
-$0.46
Consensus EPS
-$0.16
Beat/Miss
Missed by -$0.30
One Year Ago EPS
-$0.74

IMNM Q2 2023 Revenue Results

Actual Revenue
$4.26M
Expected Revenue
$0
Beat/Miss
Beat by +$4.26M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/09/2023
Time
Before Open
Conference Call
Wednesday, August 9, 2023
IMNM Upcoming Earnings

Immunome's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

IMNM Earnings History

IMNM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.72--0.76――
Nov 09, 20262026 (Q3)-0.62-0.64-0.651.08% (+0.01)
Aug 11, 20262026 (Q2)-0.51-0.65-0.5-30.00% (-0.15)
May 12, 20262026 (Q1)-0.56-0.48-0.527.69% (+0.04)
Mar 03, 20262025 (Q4)-0.59-0.76-1.1131.53% (+0.35)
Nov 06, 20252025 (Q3)-0.57-0.65-0.7816.67% (+0.13)
Aug 06, 20252025 (Q2)-0.52-0.50-0.616.67% (+0.10)
May 12, 20252025 (Q1)-0.64-0.52-2.5179.28% (+1.99)
Mar 19, 20252024 (Q4)-0.64-1.11-4.2173.63% (+3.10)
Nov 13, 20242024 (Q3)-0.55-0.78-0.36-116.67% (-0.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed